These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34207300)

  • 1. BNT162b2 mRNA SARS-CoV-2 Vaccine Elicits High Avidity and Neutralizing Antibodies in Healthcare Workers.
    Pratesi F; Caruso T; Testa D; Tarpanelli T; Gentili A; Gioè D; Migliorini P
    Vaccines (Basel); 2021 Jun; 9(6):. PubMed ID: 34207300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies.
    Caruso T; Salani F; Catanese S; Pratesi F; Mercinelli C; Motta G; Genovesi V; Bonato A; Sara G; Masi G; Migliorini P
    Int J Clin Oncol; 2023 Mar; 28(3):363-369. PubMed ID: 36689013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of anti-SARS-CoV-2 mRNA vaccine in systemic autoimmune disorders: induction of high avidity and neutralising anti-RBD antibodies.
    Tani C; Pratesi F; Talarico R; Cardelli C; Caruso T; Di Cianni F; Laurino E; Italiano N; Moretti M; Manca ML; Migliorini P; Mosca M
    RMD Open; 2021 Dec; 7(3):. PubMed ID: 34880126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers.
    Salvagno GL; Henry BM; di Piazza G; Pighi L; de Nitto S; Bragantini D; Gianfilippi GL; Lippi G
    J Med Biochem; 2021 Sep; 40(4):327-334. PubMed ID: 34616222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series.
    Danese E; Montagnana M; Salvagno GL; Peserico D; Pighi L; De Nitto S; Henry BM; Porru S; Lippi G
    Clin Chem Lab Med; 2021 Aug; 59(9):1585-1591. PubMed ID: 33838087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bimodal antibody-titer decline following BNT162b2 mRNA anti-SARS-CoV-2 vaccination in healthcare workers of the INT - IRCCS "Fondazione Pascale" Cancer Center (Naples, Italy).
    Isgrò MA; Trillò G; Russo L; Tornesello AL; Buonaguro L; Tornesello ML; Miscio L; Normanno N; Bianchi AAM; Buonaguro FM; Cavalcanti E;
    Infect Agent Cancer; 2022 Jul; 17(1):40. PubMed ID: 35902961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined monitoring of IgG and IgA anti-Spike and anti-Receptor binding domain long term responses following BNT162b2 mRNA vaccination in Greek healthcare workers.
    Sarrigeorgiou I; Moschandreou D; Dimitriadis A; Tsinti G; Sotiropoulou E; Ntoukaki E; Eliadis P; Backovic M; Labropoulou S; Escriou N; Pouliakis A; Giannopoulou G; Gaitanarou E; Lazaridis K; Mentis A; Mamalaki A; Grouzi E; Lymberi P
    PLoS One; 2022; 17(11):e0277827. PubMed ID: 36409702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of neutralizing antibodies in CLL patients after SARS-CoV-2 mRNA vaccination: a monocentric experience.
    Baratè C; Caruso T; Mavilia F; Sammuri P; Pratesi F; Motta G; Guerri V; Galimberti S; Migliorini P
    Clin Exp Med; 2023 Aug; 23(4):1197-1203. PubMed ID: 36074205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees.
    Masson LC; Servian CDP; Jardim VH; Dos Anjos D; Dorta ML; Batalha-Carvalho JV; Moro AM; Romão PRT; Souza M; Fiaccadori FS; Fonseca SG
    Vaccines (Basel); 2023 Jun; 11(7):. PubMed ID: 37514999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avidity maturation of humoral response following primary and booster doses of BNT162b2 mRNA vaccine among nursing home residents and healthcare workers.
    Oyebanji OA; Sundheimer N; Ragavapuram V; Wilson BM; Abul Y; Gravenstein S; Bosch J; King CL; Canaday DH
    Geroscience; 2024 May; ():. PubMed ID: 38789833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative longitudinal variation of total IgG and IgA anti-SARS-CoV-2 antibodies in recipients of BNT162b2 vaccination.
    Lippi G; Salvagno GL; Henry BM; Pighi L; De Nitto S; Gianfilippi G
    Adv Lab Med; 2022 Mar; 3(1):39-50. PubMed ID: 37359438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine.
    Lo Sasso B; Giglio RV; Vidali M; Scazzone C; Bivona G; Gambino CM; Ciaccio AM; Agnello L; Ciaccio M
    Diagnostics (Basel); 2021 Jun; 11(7):. PubMed ID: 34206567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody Response after BNT162b2 Vaccination in Healthcare Workers Previously Exposed and Not Exposed to SARS-CoV-2.
    Salvaggio M; Fusina F; Albani F; Salvaggio M; Beschi R; Ferrari E; Costa A; Agnoletti L; Facchi E; Natalini G
    J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing Anti-SARS-CoV-2 Antibody Titer and Reported Adverse Effects, in a Sample of Italian Nursing Home Personnel after Two Doses of the BNT162b2 Vaccine Administered Four Weeks Apart.
    Modenese A; Paduano S; Bargellini A; Bellucci R; Marchetti S; Bruno F; Grazioli P; Vivoli R; Gobba F
    Vaccines (Basel); 2021 Jun; 9(6):. PubMed ID: 34203652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of antibody immune responses between BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in naïve and previously infected individuals.
    Al-Sadeq DW; Shurrab FM; Ismail A; Amanullah FH; Thomas S; Aldewik N; Yassine HM; Abdul Rahim HF; Abu-Raddad L; Nasrallah GK
    J Travel Med; 2021 Dec; 28(8):. PubMed ID: 34888670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Dynamics of Humoral and Cell-Mediated Immunity with Three Doses of BNT162b2 SARS-CoV-2 Vaccine in Healthcare Workers in Japan: A Prospective Cohort Study.
    Yamashita K; Suzuki A; Takebayashi S; Toguchi A; Ogitani K; Niizeki N; Nagura O; Furuhashi K; Iwaizumi M; Maekawa M
    Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between Anti-SARS-CoV-2 Total Antibodies and Spike Trimeric IgG after BNT162b2 Booster Immunization.
    Salvagno GL; Lippi G
    Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The strength of association between pre-and post-booster BNT162b2 anti-SARS-CoV-2 antibodies levels depends on the immunoassay.
    Salvagno GL; Henry BM; Lippi G
    Int J Infect Dis; 2021 Oct; 111():65-67. PubMed ID: 34455083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of five commercial anti-SARS-CoV-2 total antibodies and IgG immunoassays after vaccination with BNT162b2 mRNA.
    Danese E; Montagnana M; Salvagno GL; Gelati M; Peserico D; Pighi L; de Nitto S; Henry BM; Porru S; Lippi G
    J Med Biochem; 2021 Sep; 40(4):335-340. PubMed ID: 34616223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term antibody response after 1 dose of BNT162b2 vaccine in patients receiving hemodialysis.
    Goupil R; Benlarbi M; Beaubien-Souligny W; Nadeau-Fredette AC; Chatterjee D; Goyette G; Gunaratnam L; Lamarche C; Tom A; Finzi A; Suri RS;
    CMAJ; 2021 May; 193(22):E793-E800. PubMed ID: 33980499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.